Canaccord Genuity Keeps Hold Rating on Bioceres Crop Solutions, Reduces Price Target to $2.25
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 14 2025
0mins
Source: Benzinga
Real-time Intelligence: Benzinga Pro offers traders the fastest news alerts to stay updated on market movements.
Exclusive Stories: The platform provides unique stories generated by Benzinga reporters, enhancing trading insights.
Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, sharing valuable market intelligence.
Market Winning Tool: Benzinga Pro is designed to help traders succeed in the markets by providing accurate and timely information.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BIOX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BIOX
Wall Street analysts forecast BIOX stock price to rise
1 Analyst Rating
0 Buy
1 Hold
0 Sell
Hold
Current: 0.425
Low
2.00
Averages
2.00
High
2.00
Current: 0.425
Low
2.00
Averages
2.00
High
2.00
About BIOX
Bioceres Crop Solutions Corp. is a provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Bioceres Crop Solutions Earnings Call Insights
- Revenue Decline: Bioceres Crop Solutions reported a 23% year-over-year decline in total revenue, primarily due to softer market conditions and ongoing portfolio transitions, which places financial pressure on the company and impacts future growth potential.
- Significant Gross Profit Drop: The company's gross profit fell by 30% year-over-year, with broad declines across all segments, indicating severe challenges to profitability in the current market environment, necessitating measures to improve financial health.
- Growth in Crop Nutrition: Despite the overall revenue decline, the crop nutrition segment achieved a 15% year-over-year growth, driven by increased demand for microbeaded fertilizers, suggesting that this area still holds growth potential and could become a future business highlight.
- Litigation Risks: The company is facing ongoing litigation related to the ProFarm Group, involving a non-cash impairment loss of approximately $179 million, which adds financial uncertainty and could affect investor confidence and stock performance.
See More
Bioceres Crop Solutions Reports Q3 Fiscal 2026 Earnings Decline Amid Transition
- Declining Financial Performance: Bioceres Crop Solutions reported total revenues of $39.4 million for Q3, reflecting a 23% year-over-year decline primarily due to an 18% drop in Crop Protection revenue to $24.6 million, while Seeds and Integrated Products revenue plummeted 71%, indicating significant competitive pressures in the market.
- Gross Margin Contraction: The gross profit for the quarter was $12.7 million, down from $18.1 million last year, with gross margin decreasing from 35% to 32%, highlighting challenges in cost control and the impact of product mix effects and nonrecurring adjustments on profitability.
- Increased Liquidity Risk: As of March 31, 2026, the company reported total financial debt of approximately $229 million, with cash and short-term investments totaling only $14 million, resulting in a net financial debt of about $214 million, underscoring urgent liquidity management concerns.
- Litigation Risk: The company faces heightened litigation risks as four holders of secured notes filed a lawsuit in New York, and while the company strongly disputes these allegations, the case remains in its early stages, potentially impacting future financial stability.
See More
Bioceres Reports Q3 Loss Amid Revenue Decline
- Poor Financial Performance: Bioceres reported a net loss of $10 million in Q3, with an adjusted EBITDA of negative $0.6 million, indicating significant challenges in profitability.
- Significant Revenue Decline: The company's revenue of $39.4 million represents a 22.9% year-over-year decrease, missing expectations by $15.1 million, reflecting weak market demand and increased competition.
- Market Reaction: Despite Bioceres' disappointing results, fertilizer stocks rallied due to supply fears in the Middle East, indicating heightened market interest and investor sentiment volatility.
- Uncertain Future Outlook: Given the current economic environment, Bioceres' financial performance may impact its future investment and expansion plans, necessitating close monitoring of the company's strategic adjustments and market responses.
See More
Bioceres Reports Q2 Financial Results Amid Challenges
- Financial Performance Pressure: Bioceres' Q2 financial results reveal revenue and working capital impacts due to sustained pressure on Argentine farmer economics, although the consolidated gross margin across its three business segments remains at 40%, demonstrating the resilience of its technology-driven product portfolio.
- Asset Disposal and Impairment: A foreclosure auction for Pro Farm assets occurred on January 20, 2026, with a bid of $15 million against a carrying value of approximately $194 million, resulting in a $179 million impairment loss, highlighting significant financial challenges faced by the company.
- Financing and Capital Structure: The company continues to face substantial doubt regarding its ability to secure additional financing, actively engaging with local Argentine financial institutions to refinance obligations while evaluating asset disposals and long-term financing options to restore market confidence and improve capital structure.
- Board Governance Strengthening: Bioceres has strengthened its board by adding two new non-executive directors in Q2 of fiscal 2026, focusing on enhancing governance and independent oversight to navigate current challenges and ensure transparency with shareholders.
See More
Middle East Tensions Drive Fertilizer Stocks Rally
- Market Reaction: Fertilizer stocks have rallied recently as escalating tensions in the Middle East raise concerns about nitrogen supply disruptions, with producers like CF Industries, Nutrien, and Mosaic seeing significant price increases reflecting market expectations of tighter availability.
- Supply Chain Risks: Nearly half of global urea exports and about 30% of ammonia shipments originate from conflict-affected regions, raising supply concerns just as the Northern Hemisphere's spring planting season approaches, potentially impacting crop production.
- Cost Advantage: Rising natural gas prices in Europe, a key feedstock for nitrogen fertilizer production, are widening the cost advantage for U.S. producers, enhancing their competitiveness in the global market.
- Quant Rating Performance: Within the fertilizer sector, Intrepid Potash and Mosaic have received “Strong Buy” and “Hold” ratings respectively, with 5-day performances of 3.97% and 15.75%, indicating strong market confidence in these companies.
See More
Moolec Achieves Breakthrough Results and Stock Market Reaction
- Increased Planting and Yields: Moolec cultivated approximately 1,100 acres of engineered safflower in the 2025 season, achieving an average yield of 2,200 pounds per acre, significantly up from 1,400 pounds in 2024, exceeding the company's expectations and demonstrating the effectiveness and potential of its agricultural technology.
- GLA Concentration Validation: The company confirmed gamma-linolenic acid (GLA) concentrations of around 45% from its U.S. GLASO safflower platform, marking the operational feasibility of its plant-engineered molecular farming technology for commercial-scale production, laying the groundwork for sustainable revenue.
- Nasdaq Listing Approval: On January 30, Moolec confirmed that the Nasdaq Hearings Panel approved its request for continued listing after the company regained compliance with minimum bid price requirements following a one-for-15 reverse stock split, boosting market confidence.
- Positive Stock Market Reaction: Following the announcement of strong crushing results, Moolec's shares soared over 130% on Friday, with the stock gaining 241% year-to-date, reflecting strong investor optimism regarding its future growth prospects.
See More
Bioceres Crop Solutions Earnings Call Insights
- Revenue Decline: Bioceres Crop Solutions reported a 23% year-over-year decline in total revenue, primarily due to softer market conditions and ongoing portfolio transitions, which places financial pressure on the company and impacts future growth potential.
- Significant Gross Profit Drop: The company's gross profit fell by 30% year-over-year, with broad declines across all segments, indicating severe challenges to profitability in the current market environment, necessitating measures to improve financial health.
- Growth in Crop Nutrition: Despite the overall revenue decline, the crop nutrition segment achieved a 15% year-over-year growth, driven by increased demand for microbeaded fertilizers, suggesting that this area still holds growth potential and could become a future business highlight.
- Litigation Risks: The company is facing ongoing litigation related to the ProFarm Group, involving a non-cash impairment loss of approximately $179 million, which adds financial uncertainty and could affect investor confidence and stock performance.
See More
Bioceres Crop Solutions Reports Q3 Fiscal 2026 Earnings Decline Amid Transition
- Declining Financial Performance: Bioceres Crop Solutions reported total revenues of $39.4 million for Q3, reflecting a 23% year-over-year decline primarily due to an 18% drop in Crop Protection revenue to $24.6 million, while Seeds and Integrated Products revenue plummeted 71%, indicating significant competitive pressures in the market.
- Gross Margin Contraction: The gross profit for the quarter was $12.7 million, down from $18.1 million last year, with gross margin decreasing from 35% to 32%, highlighting challenges in cost control and the impact of product mix effects and nonrecurring adjustments on profitability.
- Increased Liquidity Risk: As of March 31, 2026, the company reported total financial debt of approximately $229 million, with cash and short-term investments totaling only $14 million, resulting in a net financial debt of about $214 million, underscoring urgent liquidity management concerns.
- Litigation Risk: The company faces heightened litigation risks as four holders of secured notes filed a lawsuit in New York, and while the company strongly disputes these allegations, the case remains in its early stages, potentially impacting future financial stability.
See More
Bioceres Reports Q3 Loss Amid Revenue Decline
- Poor Financial Performance: Bioceres reported a net loss of $10 million in Q3, with an adjusted EBITDA of negative $0.6 million, indicating significant challenges in profitability.
- Significant Revenue Decline: The company's revenue of $39.4 million represents a 22.9% year-over-year decrease, missing expectations by $15.1 million, reflecting weak market demand and increased competition.
- Market Reaction: Despite Bioceres' disappointing results, fertilizer stocks rallied due to supply fears in the Middle East, indicating heightened market interest and investor sentiment volatility.
- Uncertain Future Outlook: Given the current economic environment, Bioceres' financial performance may impact its future investment and expansion plans, necessitating close monitoring of the company's strategic adjustments and market responses.
See More
Bioceres Reports Q2 Financial Results Amid Challenges
- Financial Performance Pressure: Bioceres' Q2 financial results reveal revenue and working capital impacts due to sustained pressure on Argentine farmer economics, although the consolidated gross margin across its three business segments remains at 40%, demonstrating the resilience of its technology-driven product portfolio.
- Asset Disposal and Impairment: A foreclosure auction for Pro Farm assets occurred on January 20, 2026, with a bid of $15 million against a carrying value of approximately $194 million, resulting in a $179 million impairment loss, highlighting significant financial challenges faced by the company.
- Financing and Capital Structure: The company continues to face substantial doubt regarding its ability to secure additional financing, actively engaging with local Argentine financial institutions to refinance obligations while evaluating asset disposals and long-term financing options to restore market confidence and improve capital structure.
- Board Governance Strengthening: Bioceres has strengthened its board by adding two new non-executive directors in Q2 of fiscal 2026, focusing on enhancing governance and independent oversight to navigate current challenges and ensure transparency with shareholders.
See More
Middle East Tensions Drive Fertilizer Stocks Rally
- Market Reaction: Fertilizer stocks have rallied recently as escalating tensions in the Middle East raise concerns about nitrogen supply disruptions, with producers like CF Industries, Nutrien, and Mosaic seeing significant price increases reflecting market expectations of tighter availability.
- Supply Chain Risks: Nearly half of global urea exports and about 30% of ammonia shipments originate from conflict-affected regions, raising supply concerns just as the Northern Hemisphere's spring planting season approaches, potentially impacting crop production.
- Cost Advantage: Rising natural gas prices in Europe, a key feedstock for nitrogen fertilizer production, are widening the cost advantage for U.S. producers, enhancing their competitiveness in the global market.
- Quant Rating Performance: Within the fertilizer sector, Intrepid Potash and Mosaic have received “Strong Buy” and “Hold” ratings respectively, with 5-day performances of 3.97% and 15.75%, indicating strong market confidence in these companies.
See More
Moolec Achieves Breakthrough Results and Stock Market Reaction
- Increased Planting and Yields: Moolec cultivated approximately 1,100 acres of engineered safflower in the 2025 season, achieving an average yield of 2,200 pounds per acre, significantly up from 1,400 pounds in 2024, exceeding the company's expectations and demonstrating the effectiveness and potential of its agricultural technology.
- GLA Concentration Validation: The company confirmed gamma-linolenic acid (GLA) concentrations of around 45% from its U.S. GLASO safflower platform, marking the operational feasibility of its plant-engineered molecular farming technology for commercial-scale production, laying the groundwork for sustainable revenue.
- Nasdaq Listing Approval: On January 30, Moolec confirmed that the Nasdaq Hearings Panel approved its request for continued listing after the company regained compliance with minimum bid price requirements following a one-for-15 reverse stock split, boosting market confidence.
- Positive Stock Market Reaction: Following the announcement of strong crushing results, Moolec's shares soared over 130% on Friday, with the stock gaining 241% year-to-date, reflecting strong investor optimism regarding its future growth prospects.
See More
